デフォルト表紙
市場調査レポート
商品コード
1008133

遺伝子検査市場:2020~2026年

Genetic Testing Market 2020-2026

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.11円
遺伝子検査市場:2020~2026年
出版日: 2021年05月05日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子検査の市場規模は、予測期間中に高いCAGRで拡大すると予測されています。遺伝性疾患は、1つの遺伝子の変化(単一遺伝子障害)、環境要因と遺伝子変異の組み合わせによる複数の遺伝子の変化、または染色体の破壊によって発生する可能性があります。遺伝子検査は、遺伝子または染色体の突然変異を特定するために使用される医学的検査です。遺伝子検査の主な利点は、予防できる可能性のある特定の病気のリスクを知り、病気または病気の種類や病気の原因を特定し、病気の選択肢を決定する機会です。遺伝子検査によって特定できる疾患には、乳癌および卵巣癌、加齢黄斑変性症(AMD)、双極性障害、パーキンソン病、セリアック病、および乾癬などがあります。

世界の遺伝子検査市場は、遺伝性疾患、癌、慢性疾患の蔓延により、来年には大幅に成長すると予測されています。さらに、遺伝子診断分野の医療関連企業による継続的な進歩も市場の成長を拡大しています。これらの企業は、最も蔓延している希少疾患を正確に診断するための新しくより良い検査を模索しています。その上、健康についての人々の間の意識の高まりと世界中の遺伝病による死亡率の上昇もまた、遺伝子検査の需要を増加させる主要な要因となっています。

さらに、米国、中国、日本などの国々では、(DTC)消費者向け遺伝子検査キットの採用が急速に増加しています。技術的受容の高まり、意識向上プログラム、およびコストの低下により、DTC-GTキットの市場は予測期間にわたって大幅に促進されるとみられています。ただし、新興国の診断インフラスの欠如は、市場の成長のための課題となっています。

当レポートでは、遺伝子検査市場について調査し、市場の概要とともに、技術別、タイプ別、疾患別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
  • 規則

第3章 競合情勢

  • 企業シェア分析
  • 重要な戦略分析
  • 主要企業分析
    • 主要企業分析
    • 重要な戦略分析

第4章 市場の決定要因

  • 動機
  • 抑制要因
  • 市場機会

第5章 市場細分化

  • 世界の遺伝子検査市場、技術別
    • ポリメラーゼ連鎖反応
    • DNAシーケンシング
    • 細胞遺伝学(核型分析とFISH)
    • マイクロアレイ
    • 遺伝子発現プロファイリング
  • 世界の遺伝子検査市場、タイプ別
    • 出生前および新生児の遺伝子検査
    • 予測テスト
    • 診断テスト
    • キャリアテスト
    • その他(法医学検査、着床前テスト)
  • 世界の遺伝子検査市場、疾患別
    • アルツハイマー病とパーキンソン病
    • 鎌状赤血球貧血
    • ファンコニ貧血
    • 循環器疾患
    • その他(嚢胞性線維症、デュシェンヌ型筋ジストロフィー)

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • 23Andme, Inc.
  • Abbott Laboratories
  • AutoGenomics, Inc.
  • Biocartis SA
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • Elitech Group
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Foundation Medicine, Inc.
  • Genomictree Inc.
  • Illumina, Inc.
  • Luminex Corp.
  • MedGenome, Inc.
  • Myriad Genetics, Inc.
  • NeoGenomics Laboratories, Inc.
  • Opko Health Inc.
  • PerkinElmer, Inc.
  • 7.19. Qiagen N.V.
  • 7.20. Quest Diagnostics, Inc.
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
図表

LIST OF TABLES

1. GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2020-2027 ($MILLION)

2. GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($MILLION)

3. GLOBAL POLYMERASE CHAIN REACTION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($MILLION)

4. GLOBAL DNA SEQUENCING REACTION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($MILLION)

5. GLOBAL CYTOGENETICS (KARYOTYPING AND FISH) MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($MILLION)

6. GLOBAL MICROARRAYS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($MILLION)

7. GLOBAL GENE EXPRESSION PROFILING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($MILLION)

8. GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($MILLION)

9. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($MILLION)

10. GLOBAL PREDICTIVE TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($MILLION)

11. GLOBAL DIAGNOSTIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($MILLION)

12. GLOBAL CARRIER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($MILLION)

13. GLOBAL OTHER GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($MILLION)

14. GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASE, 2020-2027 ($MILLION)

15. GLOBAL CANCER GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027

16. GLOBAL ALZHEIMER'S AND PARKINSONSGENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027

17. GLOBAL FANCONI ANAEMIAGENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027

18. GLOBAL SICKLE CELL ANAEMIAGENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027

19. GLOBAL CARDIOVASCULAR DISEASE GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027

20. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027

21. NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($MILLION)

22. NORTH AMERICAN MARKET GENETIC TESTING RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($MILLION)

23. NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($MILLION)

24. NORTH AMERICAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASE, 2020-2027 ($MILLION)

25. EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($MILLION)

26. EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($MILLION)

27. EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES, 2020-2027 ($MILLION)

28. EUROPEAN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($MILLION)

29. ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($MILLION)

30. ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($MILLION)

31. ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES, 2020-2027 ($MILLION)

32. ASIA-PACIFIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($MILLION)

33. REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($MILLION)

34. REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY DISEASES, 2020-2027 ($MILLION)

35. REST OF THE WORLD GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($MILLION)

LIST OF FIGURES

  • 1. GLOBAL GENETIC TESTING MARKET SHARE BY TECHNOLOGY, 2020 VS 2027 (%)
  • 2. GLOBAL GENETIC TESTING MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 3. GLOBAL GENETIC TESTING MARKET SHARE BY DISEASE, 2020 VS 2027 (%)

4. GLOBAL GENETIC TESTING MARKET DEVICES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%

  • 5. GLOBAL POLYMERASE CHAIN REACTION MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 6. GLOBAL DNA SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 7. GLOBAL CYTOGENETICS (KARYOTYPING AND FISH) MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 8. GLOBAL MICROARRAYS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL GENE EXPRESSION PROFILING MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL PREDICTIVE TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL DIAGNOSTIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL CARRIER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 15. GLOBAL ALZHEIMER'S AND PARKINSON'S MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 16. GLOBAL CARDIOVASCULAR DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 17. GLOBAL FANCONI ANAEMIA MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 18. GLOBAL SICKLE CELL ANAEMIA MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 19. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 20. US GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. CANADA GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. UK GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. FRANCE GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. GERMANY GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. ITALY GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. SPAIN GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. REST OF EUROPE GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. INDIA GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. JAPAN GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. CHINA GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. REST OF ASIA PACIFIC GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. LATIN AMERICA GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
  • 33. MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, 2020-2027 ($ MILLION)
目次
Product Code: OMR2023426

Global Genetic Testing Market Size, Share & Trends Analysis Report by technology (Polymerase Chain Reaction, DNA sequencing, Cytogenetics (Karyotyping and FISH), Microarrays, Gene Expression Profiling) By Type (Prenatal and New-Born Genetic Testing, Predictive Testing, Diagnostic Testing, Carrier Testing, and Other) By Diseases (Cancer, Alzheimer's and Parkinson, Fanconi Anemia, Sickle Cell Anemia, Cardiovascular Diseases, and Others), Forecast 2021-2027

The global genetic testing market is growing at a significant CAGR during the forecast period. The genetic disorder can be occurred by a change in one gene (monogenic disorder), by changes in multiple genes by a combination of environmental factors, and gene mutations, or by the destruction of chromosomes. Genetic testing is a medical test that is used for the identification of mutations in genes or chromosomes. The key benefit of genetic testing is the chance to know the risk for a certain disease that possibly can be prevented, identify the disease or a type of disease, identify the cause of a disease, to determine options for a disease. The disease that can be identified by genetic testing includes, breast and ovarian cancer, Age-Related Macular Degeneration (AMD), bipolar disorder, Parkinson's disease, celiac disease, and psoriasis.

The global genetic testing market is projected to considerably grow in the upcoming year due to the prevalence of genetic disorders, cancer, and chronic disease. Moreover, continuous advancement by the medical companies in the genetic diagnostic field is also augmenting the market growth. These companies are finding new and better tests for the accurate diagnosis of the most prevalent as well as rare diseases. Besides, the increase in awareness between people about health and the increased mortality rate due to genetic diseases across the globe is also a major factor increasing the need for demand for genetic testing.

Moreover, The adoption of (DTC) direct-to-consumer genetic testing kits in countries such as the US, China, and Japan, is increasing rapidly. With growing technological acceptances, awareness programs, and a drop in costs, the market for DTC-GT kits is likely to witness a significant boost over the forecast period. However, the lack of diagnostic infrastructure in emerging economies is a challenging factor for market growth.

Segmental Outlook

The global genetic testing market is segmented by technology, type, and disease. By technology, the market is segmented into polymerase chain reaction, DNA sequencing, cytogenetics (karyotyping and fish), microarrays, and gene expression profiling. By type, the market is divided into prenatal and newborn genetic testing, predictive testing, diagnostic testing, carrier testing, and others. Moreover, by disease type, the market is sub-segmented into cancer, Alzheimer's and Parkinson's, Fanconi anemia, sickle cell anemia, cardiovascular diseases, and others.

Global Genetic Testing Market Share by Disease, 2020 (%)

Source: OMR Global

Based on disease type, cancer segment is expected to hold a major market share during the forecast period. The need for accurate testing for cancer at the early stages and prediagnostic testing are some of the major factors for the significant market share of the segment. It is since the number of the cancer patient are very high, government and companies are trying to increase the 5-year survival rate of fatal cancers. Genetic testing aids in estimate a person's chance of developing cancer in a lifetime. Genetic tests are available for some types of cancer. These include breast cancer, ovarian cancer, colon cancer, thyroid cancer, prostate cancer, pancreatic cancer, melanoma, sarcoma, kidney cancer, and stomach cancer.

Regional Outlooks

The global genetic testing market is analyzed on the basis of the geographical regions that are contributing significantly to the growth of the market. The market report covers the analysis of four major regions into North America, Europe, Asia-Pacific, and the Rest of the World. North America is estimated to contribute a significant share in the global genetic testing market due to the high awareness among the people about advanced treatment for healthcare, well-developed healthcare infrastructure, presence of key players, and availability of drugs. Moreover, an increase in government initiatives for the enhancement of healthcare facilities and funding in research in the region is also a major factor for the significant market share of the region. In the US under the US CDC EGAPP, inventiveness has been taken by the government such as the Evaluation of Genomic Applications in Practice and Prevention which is also motivating the market growth. One of the key goals of the initiative is to timely, offer objectively, and credible information that is linked to available scientific evidence. These statistics will allow healthcare workers and payers, customers, policymakers, and others to differentiate genetic tests that are safe and useful.

Global Genetic Testing Market Growth, by Region 2020-2026

Source: OMR Global

Asia-Pacific will have considerable growth in the global Genetic Testing Market

In Asia Pacific, the market is increasing due to government initiatives in research and the increasing prevalence of chronic diseases. Apart from cancer, genetic testing processes have also come in easy reach for the diagnosis of inherited cardiovascular diseases such as cardiac amyloidosis, Brugada syndrome, and familial dilated cardiomyopathy. As the region has a high incidence of cardiovascular diseases, significant scope for genetic testing can be witnessed in the region during the forecast period.

Market Players Outlook

The report covers the analysis of various players operating in the global genetic testing market. Some of the major players covered in the report include Abbott Laboratories, Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., and Thermo Fisher Scientific, Inc. To survive in the market, these players adopt different marketing strategies such as mergers and acquisitions, product launches, and geographical expansion.

Recent Activity

In August 2020, Roche announced the US FDA clearance of FoundationOne Liquid CDx, it's a comprehensive pan-tumor liquid biopsy test, Liquid CDx analyses more than 300 cancer-related genes and multiple genomic signatures to benefit inform treatment decisions for all solid tumor cancers.

In May 2020, Myriad Genetics, Inc. announced the US FDA approval of my choice CDx for the treatment of patients having Advanced Ovarian Cancer. MyChoice CDx uses as a companion diagnostic to identify women with advanced ovarian cancer.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global female infertility diagnosis and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Key Companyanalysis
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Genetic Testing Market by Technology
    • 5.1.1. Polymerase Chain Reaction
    • 5.1.2. DNA Sequencing
    • 5.1.3. Cytogenetics (Karyotyping and FISH)
    • 5.1.4. Microarrays
    • 5.1.5. Gene Expression Profiling
  • 5.2. Global Genetic Testing Market by Type
    • 5.2.1. Prenatal and New-Born Genetic Testing
    • 5.2.2. Predictive Testing
    • 5.2.3. Diagnostic Testing
    • 5.2.4. Carrier Testing
    • 5.2.5. Other (Forensic Testing, Pre-Implantation Testing)
  • 5.3. Global Genetic Testing Market by Disease
    • 5.3.1. Cancer
    • 5.3.2. Alzheimer's and Parkinson's
    • 5.3.3. Sickle Cell Anaemia
    • 5.3.4. Fanconi Anaemia
    • 5.3.5. Cardiovascular Disease
    • 5.3.6. Others (Cystic Fibrosis, Duchenne's Muscular Dystrophy)

6. Regional Analysis

  • 6.2. North America
    • 6.2.1. United States
    • 6.2.2. Canada
  • 6.3. Europe
    • 6.3.1. UK
    • 6.3.2. Germany
    • 6.3.3. Italy
    • 6.3.4. Spain
    • 6.3.5. France
    • 6.3.6. Rest of Europe
  • 6.4. Asia-Pacific
    • 6.4.1. China
    • 6.4.2. India
    • 6.4.3. Japan
    • 6.4.4. Rest of Asia-Pacific
  • 6.5. Rest of the World

7. Company Profiles

  • 7.1. 23Andme, Inc.
  • 7.2. Abbott Laboratories
  • 7.3. AutoGenomics, Inc.
  • 7.4. Biocartis SA
  • 7.5. Biomerieux SA
  • 7.6. Bio-Rad Laboratories, Inc.
  • 7.7. Cepheid, Inc.
  • 7.8. Elitech Group
  • 7.9. Eurofins Scientific SE
  • 7.10. F. Hoffmann-La Roche Ltd.
  • 7.11. Foundation Medicine, Inc.
  • 7.12. Genomictree Inc.
  • 7.13. Illumina, Inc.
  • 7.14. Luminex Corp.
  • 7.15. MedGenome, Inc.
  • 7.16. Myriad Genetics, Inc.
  • 7.17. NeoGenomics Laboratories, Inc.
  • 7.18. Opko Health Inc.
  • 7.19. PerkinElmer, Inc.
  • 7.20. 7.19. Qiagen N.V.
  • 7.21. 7.20. Quest Diagnostics, Inc.
  • 7.22. Takara Bio, Inc.
  • 7.23. Thermo Fisher Scientific, Inc.